Clinical trial

Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics.

NCT02087332

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Prolonged release Torasemide (Britomar) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Torasemide (Diuver) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics.

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-04-01

PhasePHASE4

Conditions

Arterial Hypertensionunresolved

Chronic Heart Failureunresolved

Interventions

Prolonged release Torasemide (Britomar)DRUG

Torasemide (Diuver)DRUG

Sponsors & collaborators

Society of Specialists in Heart Failurelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02087332 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.